PharmaLytica 2024

The 10th edition of PharmaLytica, organised by Informa Markets in India, commenced at HITEX, Hyderabad

PharmaLytica 2024

Charting India’s Pharma's Path from Hyderabad

The 10th edition of PharmaLytica, organised by Informa Markets in India, commenced at HITEX, Hyderabad, focusing on redefining the pharmaceutical industry in the post-COVID era.

PharmaLytica offers a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients. The expo was nicknamed the ‘mini CPHI’ (Convention on Pharmaceutical Ingredients, the global pharma expo), owing to its impressive growth over the last decade. 

As the Indian pharmaceutical industry is projected to grow from USD 65 billion in 2024 to USD 130 billion by 2030, with a CAGR of over 10%, the expo highlights its potential trajectory. By 2047, the industry is expected to reach an impressive USD 450 billion, underscoring India's significant role in the global pharmaceutical landscape.

Hyderabad has become a substantial hub for the Pharma industry. This expo shines a spotlight on the city, bringing in renowned experts and industry leaders together for the conventions and medium and large-scale enterprises for the exhibitions. More than 35 per cent of the pharma products in India are being manufactured in the city. Hyderabad also has the maximum US FDA-approved facilities across the country.

PharmaLytica 2024 witnessed one of the largest gatherings of industry experts, technical heads, quality control and clinical researchers, purchase and packaging professionals, policy advisors, and other key stakeholders. The special inauguration ceremony was marked by the presence of key dignitaries such as Shri Ravi Uday Bhaskar, Director General, Pharmexcil; Shri AVPS Chakravarthi, Ambassador – World Packaging Organisation & Board Member, Pharmexcil; Mr. Orhan Yalman Okan, The Consul General, Consulate General of Turkey, Mr. Yogesh Mudras, Managing Director of Informa Markets in India and Mr. Rahul Deshpande, Senior Group Director, Informa Markets in India.

Highlighting the significant growth of the Pharmaceutical Industry, Shri Ravi Uday Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil), said “During the pandemic and post-pandemic period, the Indian pharmaceutical industry made significant contributions. We exported USD 27.8 billion worth of drugs in the financial year 2024, achieving a 9.6% growth rate despite numerous global challenges. We are expecting to reach more than USD 31 billion in the next financial year. 50% of our exports are going to highly regulated markets. As long as India continues to manufacture quality drugs at affordable prices, the industry will remain unmatched.”

Emphasizing the potential of pharma trade between India and Turkey, The Consul General, Consulate General of Turkey, Mr. Orhan Yalman Okan, said “Hyderabad is becoming a global city, particularly in the pharma sector, making it the pharma capital of India. Both India and Turkey are rising in this field, presenting significant trade and cooperation opportunities In 2022, the global pharmaceutical market reached a value of USD 1.5 trillion, with Turkey ranking 21st.” 

Addressing the opportunities in this sector, Mr. Yogesh Mudras, Managing Director, Informa Markets in India said, “In 2024, the Indian pharmaceutical industry remains a global leader across the entire supply chain. It ranks third in production by volume and in terms of Active Pharmaceutical Ingredients (APIs) globally. With over 500 different APIs manufactured domestically, India contributes 57% of APIs to the WHO's prequalified list. The medical devices sector in India stands at a market size of US$ 11 billion. By 2032, the India analytical laboratory instruments market is projected to hit $4142.85 million, propelled by the government's focus on boosting production, notably supported by the flourishing pharmaceutical sector. Situated in Hyderabad, the epicentre of India's bulk drug production, and nestled within South India's mature pharma ecosystem, Pharmalytica emerges as a vital regional hub for industry leaders and stakeholders with discussions surrounding emerging trends, prevalent challenges, and promising opportunities.”

This year’s edition saw participation of over 8,000 visitors and more than 200 exhibitors showcasing 1000+ brands.  They reaffirmed the need and focus of PharmaLytica as an industry event to boost and facilitate the pharmaceutical sector.  Key exhibitors include Hetero, Emvee Engineers, Schneider Electric, Integrated Cleanroom Technology, Nicomac Taikisha Clean Rooms, HLE Glascoat Ltd, Scientific Research Instruments Company, Ami Polymer and many more. 

The expos are primarily supported by industry associations such as BDMAI (Bulk Drug Manufacturers Association (India), FOPE (Federation of Pharma Entrepreneurs) and IPC (Indian Pharmacopoeia Commission). Additionally, Telangana Life Sciences serves as a supporting partner, while ETRIC is the e-mobility partner for the event.

Read more